LA Private

September 13, 2023

Stocks of the Hour: Chimeric Therapeutics, Apollo Minerals, Caspin Resources

Chimeric Therapeutics (ASX:CHM) announced the execution of a clinical study agreement with The University of Texas MD Anderson Cancer Center to support the “ADVENT-AML” Phase 1B study, for patients with newly diagnosed Acute Myeloid Leukaemia. In response, Jason B Litten, MD, Chief Medical Officer, stated, “By combining CHM 0201 with the current standard of care

Stocks of the Hour: Chimeric Therapeutics, Apollo Minerals, Caspin Resources Read More »

Air New Zealand faces worsening problems with Pratt & Whitney engines

Air New Zealand’s (ASX:AIZ) growing problems with Pratt and Whitney engines on some of its airliners appear to be worse than initially estimated and could have an impact on Trans-Tasman travel. In a statement released on Wednesday morning, the airline announced that travelers should anticipate “significant” scheduling changes in the coming months due to engine

Air New Zealand faces worsening problems with Pratt & Whitney engines Read More »